Trial Outcomes & Findings for Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment (NCT NCT00522626)
NCT ID: NCT00522626
Last Updated: 2016-03-01
Results Overview
Fetal heart rate in beats per minute
Recruitment status
COMPLETED
Target enrollment
19 participants
Primary outcome timeframe
60 minutes
Results posted on
2016-03-01
Participant Flow
Enrollment occured between May 2006 and May 2009 from a drug treatment facility treating pregnant and postpartum drug dependent women
Participant milestones
| Measure |
Observational
Opioid exposed pregnancies
|
|---|---|
|
Overall Study
STARTED
|
19
|
|
Overall Study
COMPLETED
|
12
|
|
Overall Study
NOT COMPLETED
|
7
|
Reasons for withdrawal
| Measure |
Observational
Opioid exposed pregnancies
|
|---|---|
|
Overall Study
Lost to Follow-up
|
7
|
Baseline Characteristics
Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment
Baseline characteristics by cohort
| Measure |
Observational
n=19 Participants
Opioid exposed pregnancies
|
|---|---|
|
Age, Continuous
|
30.25 years
STANDARD_DEVIATION 7.38 • n=5 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
19 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 60 minutesPopulation: Total number of subjects completing assessment
Fetal heart rate in beats per minute
Outcome measures
| Measure |
Trough Fetal Heart Rate
n=12 Participants
Opioid exposed pregnancies
|
|---|---|
|
Fetal Heart Rate
|
142.34 beats per minute
Standard Deviation 10.60
|
SECONDARY outcome
Timeframe: 120 minutesOutcome measures
Outcome data not reported
Adverse Events
Observational
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Lauren Jansson
Johns Hopkins University School of Medicine
Phone: 410-550-5438
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place